Skip to main content
Erschienen in: Journal of Cancer Education 4/2012

01.12.2012

Health Care Providers’ Perspectives of an Intervention Designed to Improve Colorectal Cancer Screening Rates in Family Medicine Residency Clinics

A Qualitative Study

verfasst von: Sara Rowe, Geoffrey Goldsmith, Robert Price, Audrey Brooks, Amanda Harvey

Erschienen in: Journal of Cancer Education | Ausgabe 4/2012

Einloggen, um Zugang zu erhalten

Abstract

The purpose of this study was to obtain feedback from family medicine residents and clinic nurses regarding a colorectal cancer screening (CRCS) intervention. Focus groups were used to ask participants three questions about their perceptions of the intervention and subsequent patient screening behaviors. Content analysis and constant comparison were used to yield two meaningful themes from the participant responses: patient-specific issues and study design issues. Patient-specific issues included: lack of education and fear, finances and insurance coverage, and compliance. Study design issues included: lack of time, a need for reminders to discuss CRCS with patients, quality of the nurse’s role, and a need for better clinical staff education and awareness. Results show ways to significantly improve future implementation of the CRCS intervention. Ultimately, future use of clinic-based CRCS interventions could be vastly improved by utilizing strategies to promote teamwork and increase the sense of mutual ownership among clinic staff.
Literatur
2.
Zurück zum Zitat US Department of Health and Human Services (DHHS), Centers for Disease Control and Prevention (2011) CDC Health Disparities and Inequalities Report—United States 2011. Morb Mortal Wkly Rep 60:42–46 US Department of Health and Human Services (DHHS), Centers for Disease Control and Prevention (2011) CDC Health Disparities and Inequalities Report—United States 2011. Morb Mortal Wkly Rep 60:42–46
3.
Zurück zum Zitat Brenes GA, Paskett ED (2000) Predictors of stage of adoption for colorectal cancer screening. Prev Med 31:410–416PubMedCrossRef Brenes GA, Paskett ED (2000) Predictors of stage of adoption for colorectal cancer screening. Prev Med 31:410–416PubMedCrossRef
4.
Zurück zum Zitat Wei EK, Ryan CT, Dietrich AJ, Colditz GA (2005) Improving colorectal cancer screening by targeting office systems in primary care practices. Arch Intern Med 165:661–666PubMedCrossRef Wei EK, Ryan CT, Dietrich AJ, Colditz GA (2005) Improving colorectal cancer screening by targeting office systems in primary care practices. Arch Intern Med 165:661–666PubMedCrossRef
5.
Zurück zum Zitat Dietrich AJ, O’Connor GT, Keller A, Carney PA, Levy D, Whaley FS (1992) Cancer: improving early and prevention; a community practice randomized trial. BMJ 304:687–691PubMedCrossRef Dietrich AJ, O’Connor GT, Keller A, Carney PA, Levy D, Whaley FS (1992) Cancer: improving early and prevention; a community practice randomized trial. BMJ 304:687–691PubMedCrossRef
6.
Zurück zum Zitat Dietrich AJ, Woodruff CB, Carney PA (1994) Changing office routines to enhance preventive care; the preventive GAPS approach. Arch Fam Med 3:176–183PubMedCrossRef Dietrich AJ, Woodruff CB, Carney PA (1994) Changing office routines to enhance preventive care; the preventive GAPS approach. Arch Fam Med 3:176–183PubMedCrossRef
7.
Zurück zum Zitat Sabatino SA, Habarta N, Baron RC, Coates RJ, Rimer BK, Kerner J, Souglin SS, Kalra GP, Chattopadhyay S (2008) Intervention to increase recommendations and delivery of screening for breast, cervical, and colorectal cancers by healthcare provider: systematic reviews of provider assessment and feedback and provider incentives. Am J Prev Med 35:67–74CrossRef Sabatino SA, Habarta N, Baron RC, Coates RJ, Rimer BK, Kerner J, Souglin SS, Kalra GP, Chattopadhyay S (2008) Intervention to increase recommendations and delivery of screening for breast, cervical, and colorectal cancers by healthcare provider: systematic reviews of provider assessment and feedback and provider incentives. Am J Prev Med 35:67–74CrossRef
8.
Zurück zum Zitat Prochaska JO, DiClemente CC (2005) The transtheorectical approach. In: Norcass JC, Goldfrid MR (eds) Handbook of psychotherapy integration, 2nd edn. Oxford University Press, New York, pp 147–171 Prochaska JO, DiClemente CC (2005) The transtheorectical approach. In: Norcass JC, Goldfrid MR (eds) Handbook of psychotherapy integration, 2nd edn. Oxford University Press, New York, pp 147–171
9.
Zurück zum Zitat Goldsmith G, Chiaro C (2008) Colorectal cancer screening: how to help patients comply. J Fam Pract 57:2–7 Goldsmith G, Chiaro C (2008) Colorectal cancer screening: how to help patients comply. J Fam Pract 57:2–7
11.
Zurück zum Zitat Krueger RA (1994) Focus groups: a practical guide for applied research, 2nd edn. Sage, Thousand Oaks Krueger RA (1994) Focus groups: a practical guide for applied research, 2nd edn. Sage, Thousand Oaks
12.
Zurück zum Zitat Wengraf T (2001) Qualitative research interviewing: biographic narratives and semi-structured methods. Sage, London, England Wengraf T (2001) Qualitative research interviewing: biographic narratives and semi-structured methods. Sage, London, England
13.
Zurück zum Zitat Lawson L, Rowe S (2010) Treatment of females convicted of molesting children. J Forensic Nurs 6:180–187PubMedCrossRef Lawson L, Rowe S (2010) Treatment of females convicted of molesting children. J Forensic Nurs 6:180–187PubMedCrossRef
14.
Zurück zum Zitat Robinson-Wolf Z (2007) Ethnography: the method. In: Munahll P (ed) Nursing research: a qualitative perspective, 4th edn. Jones and Barlett, Sudbury, pp 293–319 Robinson-Wolf Z (2007) Ethnography: the method. In: Munahll P (ed) Nursing research: a qualitative perspective, 4th edn. Jones and Barlett, Sudbury, pp 293–319
15.
Zurück zum Zitat Streubert H, Carpenter D (1999) Qualitative research in nursing: advancing the humanistic imperative, 2nd edn. Lippincott, Philadelphia Streubert H, Carpenter D (1999) Qualitative research in nursing: advancing the humanistic imperative, 2nd edn. Lippincott, Philadelphia
16.
Zurück zum Zitat Curry LA, Spatz E, Cherlin E, Thompson JW, Berg D, Ting HH, Decker C, Krumholz HM, Bradley EH (2011) What distinguishes top-performing hospitals in acute myocardial infarction mortality rates? Ann Intern Med 154:384–390PubMed Curry LA, Spatz E, Cherlin E, Thompson JW, Berg D, Ting HH, Decker C, Krumholz HM, Bradley EH (2011) What distinguishes top-performing hospitals in acute myocardial infarction mortality rates? Ann Intern Med 154:384–390PubMed
17.
Zurück zum Zitat Berwick DM (2002) A user’s manual for the IOM’s Quality Chasm report. Heal Aff 21:80–90CrossRef Berwick DM (2002) A user’s manual for the IOM’s Quality Chasm report. Heal Aff 21:80–90CrossRef
18.
Zurück zum Zitat Collins J (2006) Good to great: why some companies make the leap… and others don’t. Harper Collins, New York Collins J (2006) Good to great: why some companies make the leap… and others don’t. Harper Collins, New York
Metadaten
Titel
Health Care Providers’ Perspectives of an Intervention Designed to Improve Colorectal Cancer Screening Rates in Family Medicine Residency Clinics
A Qualitative Study
verfasst von
Sara Rowe
Geoffrey Goldsmith
Robert Price
Audrey Brooks
Amanda Harvey
Publikationsdatum
01.12.2012
Verlag
Springer-Verlag
Erschienen in
Journal of Cancer Education / Ausgabe 4/2012
Print ISSN: 0885-8195
Elektronische ISSN: 1543-0154
DOI
https://doi.org/10.1007/s13187-012-0393-5

Weitere Artikel der Ausgabe 4/2012

Journal of Cancer Education 4/2012 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.